- Home
- CLPT vs BWAY Comparison
CLPT vs BWAY Comparison
Compare CLPT & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- BWAY
- Stock Information
- Founded
- CLPT 1998
- BWAY 2003
- Country
- CLPT United States
- BWAY Israel
- Employees
- CLPT N/A
- BWAY N/A
- Industry
- CLPT Medical/Dental Instruments
- BWAY Medical/Dental Instruments
- Sector
- CLPT Health Care
- BWAY Health Care
- Exchange
- CLPT Nasdaq
- BWAY Nasdaq
- Market Cap
- CLPT 318.4M
- BWAY 280.7M
- IPO Year
- CLPT N/A
- BWAY 2019
- Fundamental
- Price
- CLPT $27.01
- BWAY N/A
- Analyst Decision
- CLPT Strong Buy
- BWAY Strong Buy
- Analyst Count
- CLPT 3
- BWAY 2
- Target Price
- CLPT $27.67
- BWAY $18.00
- AVG Volume (30 Days)
- CLPT 1.5M
- BWAY 61.1K
- Earning Date
- CLPT 11-06-2025
- BWAY 11-11-2025
- Dividend Yield
- CLPT N/A
- BWAY N/A
- EPS Growth
- CLPT N/A
- BWAY 679.98
- EPS
- CLPT N/A
- BWAY 0.11
- Revenue
- CLPT $33,593,000.00
- BWAY $46,084,000.00
- Revenue This Year
- CLPT $22.34
- BWAY $335.63
- Revenue Next Year
- CLPT $25.50
- BWAY $22.10
- P/E Ratio
- CLPT N/A
- BWAY $55.30
- Revenue Growth
- CLPT 19.68
- BWAY 26.50
- 52 Week Low
- CLPT $9.76
- BWAY $7.84
- 52 Week High
- CLPT $28.80
- BWAY $17.00
- Technical
- Relative Strength Index (RSI)
- CLPT 84.97
- BWAY 51.50
- Support Level
- CLPT $20.16
- BWAY $14.61
- Resistance Level
- CLPT $28.80
- BWAY $15.60
- Average True Range (ATR)
- CLPT 1.93
- BWAY 0.66
- MACD
- CLPT 1.29
- BWAY -0.12
- Stochastic Oscillator
- CLPT 87.87
- BWAY 41.78
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.